Market Overview

UPDATE: Morgan Stanley Reiterates On PHH As Fleet Sale Is Complete

Share:

In a report published Tuesday, Morgan Stanley analyst Cheryl M. Pate reiterated an Equal-Weight rating on PHH (NYSE: PHH), but removed the $24.00 price target.

In the report, Morgan Stanley noted, “The $450m in buyback authority, with $200m accelerated following 2Q earnings, is faster and slightly more than double our current forecast ($220m from 4Q14 through YE15). We assume the accelerated buybacks will take place in 3Q14 and the remaining $250m will be done evenly over the next four quarters (beginning 4Q14). Under these assumptions, we believe the higher-than-forecast buybacks are accretable to our TBV estimate. We expect the stock will begin to re-rate up with clarity on excess cash usage.”

PHH closed on Monday at $23.28.

Latest Ratings for PHH

DateFirmActionFromTo
Jun 2017DowngradesOutperformNeutral
Mar 2017UpgradesNeutralOutperform
Oct 2016Initiates Coverage OnNeutral

View More Analyst Ratings for PHH
View the Latest Analyst Ratings

Posted-In: Cheryl M. Pate Morgan StanleyAnalyst Color Price Target Analyst Ratings

 

Related Articles (PHH)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
THCBarclaysMaintains33.0
DVABarclaysMaintains79.0
ARABarclaysMaintains9.0
VRTXCantor FitzgeraldMaintains229.0
HCMCLSAInitiates Coverage On
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

UPDATE: Morgan Stanley Reiterates On Atmel On Good Market Position

Philips Healthcare CEO To Pursue 'Other Opportunities'